샘플 요청 목록

 카트 문의
시장보고서
상품코드
1793873

세계의 매독 면역분석법 진단약 시장

Syphilis Immunoassay Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 372 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 매독 면역분석법 진단약 시장은 2030년까지 4억 4,510만 달러에 달할 전망

2024년에 3억 5,660만 달러로 추정되는 세계의 매독 면역분석법 진단약 시장은 2024-2030년에 CAGR 3.8%로 성장하며, 2030년에는 4억 4,510만 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 애널라이저는 CAGR 3.0%를 기록하며, 분석 기간 종료시에는 2억 6,110만 달러에 달할 것으로 예측됩니다. 키트 & 시약 부문의 성장률은 분석 기간에 CAGR 4.9%로 추정됩니다.

미국 시장은 9,710만 달러로 추정·중국은 CAGR 6.8%로 성장 예측

미국의 매독 면역분석법 진단약 시장은 2024년에는 9,710만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 8,900만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 6.8%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.6%와 2.9%로 예측됩니다. 유럽에서는 독일이 CAGR 2.2%로 성장할 것으로 예측됩니다.

세계의 매독 면역분석법 진단약 시장 - 주요 동향과 촉진요인 정리

면역 분석 기반 검사가 매독 진단의 중심이 되고 있는 이유는 무엇인가?

매독 면역 분석 진단은 높은 특이성, 확장성, 활성 및 잠복 감염을 모두 검출할 수 있는 능력으로 인해 성병(STI) 스크리닝의 핵심이 되고 있습니다. 항원 항체 결합에 의존하여 트레포네마를 검출하는 이 검사법은 병원, 성병 클리닉, 공중 보건 연구소에서 일상적인 검사 및 확인 검사로 채택되고 있습니다. 고위험군 및 HIV 동시 감염자를 포함한 매독의 세계적 재유행을 고려할 때, 그 사용 증가는 특히 중요합니다.

특히 자원이 한정된 지역에서 신속한 치료 결정을 내릴 수 있도록 분산된 의료 환경에서 신속한 현장 면역측정법이 채택되고 있습니다. 자동 면역 분석기는 중앙 집중식 실험실의 표준이 되었으며, 다른 STI와 함께 높은 처리량으로 다중 검사를 제공합니다. 산전 검진 프로그램에 통합되어 선천성 매독 예방에도 필수적인 역할을 하고 있습니다. 조기발견과 조기치료가 정책적으로 강조되고 있는 현재, 면역측정법은 전 세계 매독 대책의 최전선에 서 있습니다.

매독 면역 분석 진단의 정확도와 도달 범위를 높이는 기술은 무엇인가?

면역 분석 플랫폼의 진화로 분석 성능이 크게 향상되었습니다. 화학발광면역측정법(CLIA), 효소결합면역흡착법(ELISA) 및 형광 기반 시스템은 현재 다양한 단계에 걸쳐 우수한 민감도와 특이성을 제공합니다. 트레포네마 항체와 비트레포네마 항체의 이중 검출 형태는 위음성을 줄이고 종합적인 혈청학적 프로파일링을 가능하게 하기 위해 통합되고 있습니다.

소형화와 마이크로플루이딕스학으로 인해 실험실 인프라 없이도 몇 분 안에 결과를 얻을 수 있는 핸드헬드 기기에서 신속한 면역 분석이 가능해졌습니다. 하나의 카트리지로 매독과 HIV, 간염을 동시에 검사할 수 있는 다중 면역측정법이 개발되었습니다. 또한 AI 기반 이미지 인식 툴은 숙련도가 낮은 환경에서 보다 일관된 측방유동 어세이을 해석하기 위해 AI 기반 이미지 인식 툴이 사용되고 있습니다. 이러한 기술적 진보는 취약 계층과 이동 진료소에서 검진을 확대하는 데 필수적입니다.

매독 검출을 위해 면역 분석의 채택이 가장 빠르게 증가하고 있는 곳은 어디인가?

성장률이 높은 시장으로는 매독 유병률이 높고 의료시스템이 현대화되어 있는 사하라 사막 이남 아프리카, 동남아시아, 라틴아메리카 등이 있습니다. 공중보건 구상은 조기 진단을 촉진하고 감염을 줄이기 위해 지역 진료소, 이동 진료소, 산모 건강 프로그램에서 신속 검사 키트를 적극적으로 배포하고 있습니다.

개발도상국에서는 고위험군에 대한 정기적인 검진 권고가 확대되면서성 건강 클리닉, 혈액 은행, 교정 시설에서 실험실 기반 면역 분석에 대한 수요가 증가하고 있습니다. 원격의료 및 재택 검사 프로바이더를 포함한 민간 부문도 면역측정법을 STI 키트에 통합하여 소비자에게 직접 제공합니다. 이러한 채택 채널을 통해 매독 면역 분석 진단약은 전 세계 보건의료 환경에 널리 보급되어 그 유용성이 높아지고 있습니다.

매독 면역 분석 진단 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다.

매독 면역 분석 진단 시장의 성장은 전 세계에서 STI 사례 증가, 면역 분석의 민감도 및 휴대성 향상, 조기 및 대량 검진에 대한 공중 보건의 의무화 증가로 인해 발생할 수 있습니다. 임상 실험실에서 자동화된 하이스루풋 플랫폼의 통합은 대규모 스크리닝 작업을 간소화하고 있습니다.

특히 산모와 신생아 보건 프로그램에서 신속한 처리 시간을 보장하는 현장진단형 면역측정법은 원격지나 의료서비스가 부족한 지역에서의 진단을 지원하고 있습니다. 멀티플렉스 플랫폼과 디지털화된 검사 해석 툴의 성장으로 검사 정확도와 업무 효율성이 향상되고 있습니다. 또한 감염병 감시 및 국제 원조 프로그램에 대한 투자가 증가함에 따라 전 세계에서 저렴한 가격과 품질이 보장된 진단 키트에 대한 접근성이 확대되고 있습니다.

부문

제품(분석기, 키트 & 시약); 기술(CLIA, ELISA); 최종 사용(혈액은행 최종 사용, 진단 실험실 최종 사용, 병원 최종 사용, 기타 최종 사용)

조사 대상 기업의 예

  • Abbott Laboratories
  • AccuQuik(Jal Medical)
  • Becton, Dickinson & Company(BD)
  • bioMerieux SA
  • Bio-Rad Laboratories
  • Chembio Diagnostic Systems
  • Danaher Corporation(Beckman Coulter)
  • DiaSorin S.p.A.
  • Fujirebio
  • New Industries Biomedical Engineering(SNIBE)
  • NOWDiagnostics(NOWDx)
  • QuidelOrtho Corporation
  • Roche Diagnostics(F. Hoffmann-La Roche)
  • Sekisui Chemical Co., Ltd.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Siemens Healthineers AG
  • Stanbio(Sekisui Specialty Diagnostics)
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech

AI 통합

당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.28

Global Syphilis Immunoassay Diagnostics Market to Reach US$445.1 Million by 2030

The global market for Syphilis Immunoassay Diagnostics estimated at US$356.6 Million in the year 2024, is expected to reach US$445.1 Million by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Analyzer, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$261.1 Million by the end of the analysis period. Growth in the Kit & Reagent segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$97.1 Million While China is Forecast to Grow at 6.8% CAGR

The Syphilis Immunoassay Diagnostics market in the U.S. is estimated at US$97.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$89.0 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Syphilis Immunoassay Diagnostics Market - Key Trends & Drivers Summarized

Why Are Immunoassay-Based Tests Becoming Central to Syphilis Diagnosis?

Syphilis immunoassay diagnostics have become a cornerstone in sexually transmitted infection (STI) screening due to their high specificity, scalability, and ability to detect both active and latent infections. These assays, which rely on antigen-antibody binding to detect Treponema pallidum, are employed across hospitals, sexual health clinics, and public health labs for routine and confirmatory testing. Their growing use is especially significant given the global resurgence of syphilis, including among high-risk populations and co-infected individuals with HIV.

Rapid point-of-care immunoassays are being adopted in decentralized healthcare settings, enabling faster treatment decisions, particularly in resource-limited regions. Automated immunoassay analyzers have become standard in centralized labs, offering high-throughput, multiplex testing alongside other STIs. Their integration into antenatal screening programs has also made them essential in preventing congenital syphilis. With increasing policy emphasis on early detection and treatment, immunoassay diagnostics now form the front line in syphilis control efforts worldwide.

How Is Technology Elevating Syphilis Immunoassay Diagnostic Accuracy and Reach?

The evolution of immunoassay platforms has significantly improved analytical performance. Chemiluminescent immunoassays (CLIA), enzyme-linked immunosorbent assays (ELISA), and fluorescence-based systems now offer superior sensitivity and specificity across different disease stages. Dual treponemal and non-treponemal antibody detection formats are being integrated to reduce false negatives and enable comprehensive serological profiling.

Miniaturization and microfluidics are enabling rapid immunoassays on handheld devices that deliver results within minutes without lab infrastructure. Multiplex immunoassays are being developed to test syphilis alongside HIV and hepatitis in a single cartridge. Additionally, AI-powered image recognition tools are being used to interpret lateral flow assays with greater consistency in low-skill settings. These technological advances are crucial for scaling up screening in vulnerable populations and in mobile healthcare units.

Where Is Immunoassay Adoption Increasing Most Rapidly for Syphilis Detection?

High-growth markets include sub-Saharan Africa, Southeast Asia, and Latin America-regions where syphilis prevalence is high and healthcare systems are undergoing diagnostic modernization. Public health initiatives are actively distributing rapid test kits in community clinics, mobile units, and maternal health programs to facilitate early diagnosis and reduce transmission.

Developed nations are expanding routine screening recommendations for high-risk groups, driving demand for lab-based immunoassays in sexual health clinics, blood banks, and correctional facilities. The private sector, including telehealth and at-home testing providers, is also incorporating immunoassays into direct-to-consumer STI kits. Together, these adoption channels are widening the reach and utility of syphilis immunoassay diagnostics across global health landscapes.

The Growth in the Syphilis Immunoassay Diagnostics Market Is Driven by Several Factors…

It is driven by the global rise in STI cases, advances in immunoassay sensitivity and portability, and increasing public health mandates for early and mass screening. The integration of automated, high-throughput platforms in clinical laboratories is streamlining large-scale screening efforts.

Point-of-care immunoassays with rapid turnaround are supporting diagnostics in remote or underserved regions, particularly within maternal and neonatal health programs. The growth of multiplex platforms and digitized assay interpretation tools is improving test accuracy and operational efficiency. Additionally, increased investment in infectious disease surveillance and international aid programs is expanding access to affordable, quality-assured diagnostic kits worldwide.

SCOPE OF STUDY:

The report analyzes the Syphilis Immunoassay Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Analyzer, Kit & Reagent); Technology (CLIA, ELISA); End-Use (Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • AccuQuik (Jal Medical)
  • Becton, Dickinson & Company (BD)
  • bioMerieux SA
  • Bio-Rad Laboratories
  • Chembio Diagnostic Systems
  • Danaher Corporation (Beckman Coulter)
  • DiaSorin S.p.A.
  • Fujirebio
  • New Industries Biomedical Engineering (SNIBE)
  • NOWDiagnostics (NOWDx)
  • QuidelOrtho Corporation
  • Roche Diagnostics (F. Hoffmann-La Roche)
  • Sekisui Chemical Co., Ltd.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Siemens Healthineers AG
  • Stanbio (Sekisui Specialty Diagnostics)
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Syphilis Immunoassay Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Syphilis Infections Drives Demand for Accurate Diagnostic Solutions
    • Increased Focus on Early Detection and Screening Programs Expands Use of Immunoassay Tests
    • Advancements in Rapid Point-of-Care Immunoassay Kits Enhance Testing Accessibility
    • Integration of Syphilis Screening Into Routine Antenatal Care Programs Spurs Market Growth
    • Technological Innovation in CLIA and ELISA Platforms Improves Test Sensitivity and Specificity
    • Demand for Multiplex STI Panels Including Syphilis Accelerates Test Consolidation in Labs
    • Growth in Public Health Funding for STI Control Drives Immunoassay Procurement
    • Increased Testing Compliance Mandates in High-Risk Populations Strengthens Diagnostic Uptake
    • Expansion of Sexual Health Clinics and Outreach Programs Fuels Volume-Based Test Adoption
    • Migration Trends and Urbanization Create New Testing Needs in Emerging Economies
    • Rise in Asymptomatic Infections Supports Use of Immunoassays for Population-Wide Surveillance
    • Digital Integration With Laboratory Information Systems Enhances Workflow and Result Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Syphilis Immunoassay Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Analyzer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Analyzer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Analyzer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Kit & Reagent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Kit & Reagent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Kit & Reagent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for CLIA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for CLIA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for CLIA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for ELISA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for ELISA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Blood Bank End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Blood Bank End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Blood Bank End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Lab End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Lab End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Diagnostic Lab End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: France 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: France 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: India 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: India 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: India 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Syphilis Immunoassay Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Syphilis Immunoassay Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Syphilis Immunoassay Diagnostics by Product - Analyzer and Kit & Reagent Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Syphilis Immunoassay Diagnostics by Product - Percentage Breakdown of Value Sales for Analyzer and Kit & Reagent for the Years 2014, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Syphilis Immunoassay Diagnostics by Technology - CLIA and ELISA Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Syphilis Immunoassay Diagnostics by Technology - Percentage Breakdown of Value Sales for CLIA and ELISA for the Years 2014, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Syphilis Immunoassay Diagnostics by End-Use - Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Syphilis Immunoassay Diagnostics by End-Use - Percentage Breakdown of Value Sales for Blood Bank End-Use, Diagnostic Lab End-Use, Hospital End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제